↓ Skip to main content

Orthosiphon stamineus Leaf Extract Affects TNF-α and Seizures in a Zebrafish Model

Overview of attention for article published in Frontiers in Pharmacology, February 2018
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (61st percentile)
  • Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

twitter
5 X users

Readers on

mendeley
60 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Orthosiphon stamineus Leaf Extract Affects TNF-α and Seizures in a Zebrafish Model
Published in
Frontiers in Pharmacology, February 2018
DOI 10.3389/fphar.2018.00139
Pubmed ID
Authors

Brandon Kar Meng Choo, Uday P. Kundap, Yatinesh Kumari, Seow-Mun Hue, Iekhsan Othman, Mohd Farooq Shaikh

Abstract

Epileptic seizures result from abnormal brain activity and can affect motor, autonomic and sensory function; as well as, memory, cognition, behavior, or emotional state. Effective anti-epileptic drugs (AEDs) are available but have tolerability issues due to their side effects. The Malaysian herb Orthosiphon stamineus, is a traditional epilepsy remedy and possesses anti-inflammatory, anti-oxidant and free-radical scavenging abilities, all of which are known to protect against seizures. This experiment thus aimed to explore if an ethanolic leaf extract of O. stamineus has the potential to be a novel symptomatic treatment for epileptic seizures in a zebrafish model; and the effects of the extract on the expression levels of several genes in the zebrafish brain which are associated with seizures. The results of this study indicate that O. stamineus has the potential to be a novel symptomatic treatment for epileptic seizures as it is pharmacologically active against seizures in a zebrafish model. The anti-convulsive effect of this extract is also comparable to that of diazepam at higher doses and can surpass diazepam in certain cases. Treatment with the extract also counteracts the upregulation of NF-κB, NPY and TNF-α as a result of a Pentylenetetrazol (PTZ) treated seizure. The anti-convulsive action for this extract could be at least partially due to its downregulation of TNF-α. Future work could include the discovery of the active anti-convulsive compound, as well as determine if the extract does not cause cognitive impairment in zebrafish.

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 60 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 60 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 16 27%
Student > Master 7 12%
Student > Ph. D. Student 5 8%
Professor > Associate Professor 4 7%
Researcher 4 7%
Other 4 7%
Unknown 20 33%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 10 17%
Pharmacology, Toxicology and Pharmaceutical Science 6 10%
Medicine and Dentistry 5 8%
Neuroscience 5 8%
Psychology 3 5%
Other 5 8%
Unknown 26 43%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 March 2018.
All research outputs
#7,209,372
of 23,025,074 outputs
Outputs from Frontiers in Pharmacology
#3,011
of 16,332 outputs
Outputs of similar age
#126,036
of 330,325 outputs
Outputs of similar age from Frontiers in Pharmacology
#75
of 343 outputs
Altmetric has tracked 23,025,074 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 16,332 research outputs from this source. They receive a mean Attention Score of 5.0. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 330,325 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.
We're also able to compare this research output to 343 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.